Thermo Fisher Scientific Ion AmpliSeq SARS-CoV-2 Research Panel

Friday, 08 May, 2020 | Supplied by: Thermo Fisher Scientific



As countries begin to ease restrictions and allow some businesses to reopen, contact tracing and epidemiological studies will be critical to understand resurgence of potential COVID-19 outbreaks. Scientists not only need to know who is infected, they also need to rapidly identify which strain of the virus is spreading.

To expedite such analysis, Thermo Fisher Scientific has optimised its Ion AmpliSeq SARS-CoV-2 Research Panel, previously designed to run on the Ion GeneStudio S5 System, for the Ion Torrent Genexus System. The panel is useful for laboratories that intend to sequence SARS-CoV-2 coronavirus samples.

A versatile, turnkey solution with a simple-to-implement workflow, the Genexus System’s ease of use has been developed to provide all researchers — regardless of expertise level — access to the power of next-generation sequencing (NGS) technology, which provides scientists a high-throughput method to quickly analyse the virus’s genetic code and trace its origin. Doing so with the Genexus System, an automated NGS platform can provide results in about 24 h.

The platform’s fast speed and automation are designed to accelerate a broad range of applications, including oncology, infectious disease and reproductive health, among others.

Online: thermofisher.com
Phone: 1300 735 292
Related Products

Illumina DNA PCR-Free Library Prep Kit

The Illumina DNA PCR-Free Library Prep Kit, for whole genome sequencing, delivers high...

Sartorius BIOSTAT STR Generation 3 bioreactor with BIOBRAIN automation platform

Engineered to address the rigorous requirements and complexity of biologics manufacture,...

DuPont DELRIN SC698 resin for medical devices

The DELRIN SC698 resin with integrated lubrication can help improve patient comfort and ease of...


  • All content Copyright © 2020 Westwick-Farrow Pty Ltd